Use of Tirzepatide:
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide
Tirzepatide is a dual GIP and GLP-1 receptor agonist developed for metabolic disorders. Its core synthesis involves solid-phase peptide coupling with Fmoc chemistry. The molecular formula is C276H425N67O80S, and the CAS number is 2128697-88-4.
Strictly contraindicated in patients with personal or family history of medullary thyroid carcinoma. Storage requires temperatures between 2°C to 8°C to maintain stability. Handling mandates PPE due to potential sensitization risks.